Back
Direxion Daily S&P Biotech Bear 3X Shares Vs. MiNK Therapeutics, Inc. Industry Stock Comparison
Sell
23
LABD
Direxion Daily S&P Biotech Bear 3X Shares
Last Price:
$21.68
Seasonality Move:
-0.37%
Sell
36
INKT
MiNK Therapeutics, Inc.
Last Price:
$11.91
Seasonality Move:
-18.07%
Sell
23
Direxion Daily S&P Biotech Bear 3X Shares (LABD)
is a Sell
Is Direxion Daily S&P Biotech Bear 3X Shares a Buy, Sell or Hold?
-
The current Direxion Daily S&P Biotech Bear 3X Shares [LABD] share price is $21.21. The Score for LABD is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
LABD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
MiNK Therapeutics, Inc. (INKT)
is a Sell
Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?
-
The current MiNK Therapeutics, Inc. [INKT] share price is $12.18. The Score for INKT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
INKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LABD Stock Price Chart
What is Direxion Daily S&P Biotech Bear 3X Shares's stock price today?
-
The Direxion Daily S&P Biotech Bear 3X Shares share price today is $21.21Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LABD is experiencing slight buying pressure.
INKT Stock Price Chart
What is MiNK Therapeutics, Inc.'s stock price today?
-
The MiNK Therapeutics, Inc. share price today is $12.18Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing selling pressure, which indicates risk of future bearish movement.
LABD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.25 | Sell |
| Relative Strength Index (14 RSI): | 34.61 | Sell |
| Chaikin Money Flow: | 944038 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.06 - 26.6) | Sell |
| Bollinger Bands (100): | (26.1 - 55.96) | Sell |
INKT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 49.45 | Sell |
| Chaikin Money Flow: | -21857 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.89 - 12.95) | Buy |
| Bollinger Bands (100): | (12.31 - 15.53) | Sell |
LABD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.22 | Sell |
| 20-day SMA: | 22.86 | Sell |
| 50-day SMA: | 27.89 | Sell |
| 200-day SMA: | 61.86 | Sell |
| 8-day EMA: | 21.49 | Sell |
| 20-day EMA: | 23.14 | Sell |
| 50-day EMA: | 29.07 | Sell |
| 200-day EMA: | 51.93 | Sell |
INKT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.34 | Sell |
| 20-day SMA: | 11.54 | Buy |
| 50-day SMA: | 13.05 | Sell |
| 200-day SMA: | 11.82 | Buy |
| 8-day EMA: | 12.2 | Sell |
| 20-day EMA: | 12.1 | Buy |
| 50-day EMA: | 12.75 | Sell |
| 200-day EMA: | 12.24 | Sell |
Direxion Daily S&P Biotech Bear 3X Shares Earnings Growth & LABD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.
Direxion Daily S&P Biotech Bear 3X Shares Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
MiNK Therapeutics, Inc. Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||